{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:31:30Z","timestamp":1790271090518,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,9,24]]},"DOI":"10.1001\/jama.2019.13206","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T12:30:35Z","timestamp":1568896235000},"page":"1167","source":"Crossref","is-referenced-by-count":66,"title":["Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function"],"prefix":"10.1001","volume":"322","author":[{"given":"Christianne L.","family":"Roumie","sequence":"first","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chipman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jea Young","family":"Min","sequence":"additional","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber J.","family":"Hackstadt","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M.","family":"Hung","sequence":"additional","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Robert A.","family":"Greevy","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Elasy","sequence":"additional","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Veteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center, Nashville"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville"},{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"joi190099r1","doi-asserted-by":"publisher","first-page":"e0173428","DOI":"10.1371\/journal.pone.0173428","article-title":"Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012.","volume":"12","author":"Geiss","year":"2017","journal-title":"PLoS One"},{"issue":"9131","key":"joi190099r2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"joi190099r3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2337\/dc17-S003","article-title":"Standards of medical care in diabetes 2017: summary of revisions.","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"9","key":"joi190099r4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","article-title":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.","volume":"157","author":"Roumie","year":"2012","journal-title":"Ann Intern Med"},{"issue":"15","key":"joi190099r5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","article-title":"Long-term follow-up after tight control of blood pressure in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"joi190099r6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"joi190099r7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2337\/dc16-1943","article-title":"Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies.","volume":"40","author":"Azoulay","year":"2017","journal-title":"Diabetes Care"},{"issue":"9131","key":"joi190099r9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"joi190099r10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes.","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"joi190099r11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"joi190099r12","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"joi190099r13","doi-asserted-by":"crossref","DOI":"10.5600\/mmrr.002.03.A06","article-title":"Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004.","volume":"2","author":"Humensky","year":"2012","journal-title":"Medicare Medicaid Res Rev"},{"issue":"3","key":"joi190099r14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/01.mlr.0000244657.90074.b7","article-title":"Veterans\u2019 access to and use of Medicare and Veterans Affairs health care.","volume":"45","author":"Hynes","year":"2007","journal-title":"Med Care"},{"issue":"8","key":"joi190099r15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/aje\/kwp010","article-title":"Suicide mortality among patients receiving care in the Veterans Health Administration health system.","volume":"169","author":"McCarthy","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"6","key":"joi190099r17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/clpt.2011.228","article-title":"Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling.","volume":"90","author":"Greevy","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"joi190099r18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/EDE.0b013e3182821e75","article-title":"Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization.","volume":"24","author":"Niesner","year":"2013","journal-title":"Epidemiology"},{"issue":"12","key":"joi190099r19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","article-title":"Antipsychotics and the risk of sudden cardiac death.","volume":"58","author":"Ray","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"joi190099r20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"24","key":"joi190099r21","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"joi190099r22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ahj.2011.06.006","article-title":"Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.","volume":"162","author":"Skali","year":"2011","journal-title":"Am Heart J"},{"issue":"451","key":"joi190099r24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/01621459.2000.10474263","article-title":"Estimating and using propensity scores with partially missing data.","volume":"95","author":"D\u2019Agostino","year":"2000","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"joi190099r25","first-page":"1946","article-title":"Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.","volume":"36","author":"Franklin","year":"2017","journal-title":"Stat Med"},{"key":"joi190099r26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"6","key":"joi190099r27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"joi190099r28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10985-014-9313-9","article-title":"Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals.","volume":"21","author":"Li","year":"2015","journal-title":"Lifetime Data Anal"},{"issue":"466","key":"joi190099r29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"joi190099r30","doi-asserted-by":"crossref","DOI":"10.2337\/dc07-0650","article-title":"Changing incident diabetes regimens: a Veterans Administration cohort study from 2000 to 2005.","volume":"30","author":"Huizinga","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"joi190099r31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12902-016-0101-2","article-title":"Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.","volume":"16","author":"Roumie","year":"2016","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"joi190099r32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/M16-1901","article-title":"Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review.","volume":"166","author":"Crowley","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"joi190099r33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/jamainternmed.2014.6936","article-title":"Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications.","volume":"175","author":"Flory","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"24","key":"joi190099r37","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review.","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"joi190099r38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register.","volume":"2","author":"Ekstr\u00f6m","year":"2012","journal-title":"BMJ Open"},{"issue":"5","key":"joi190099r39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.CIR.0000154542.13412.B1","article-title":"Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.","volume":"111","author":"Masoudi","year":"2005","journal-title":"Circulation"},{"key":"joi190099r23","doi-asserted-by":"crossref","DOI":"10.1201\/b11826","volume-title":"Flexible Imputation of Missing Data","author":"vanBuuren","year":"2012"},{"key":"joi190099r8","unstructured":"Food Drug Administration. Center for Drug Evaluation and Research application number: 20-357\/s019: final printed label: Glucophage. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2000\/20357S019_Glucophage_prntlbl.pdf. Accessed January 5, 2015."},{"key":"joi190099r16","unstructured":"Center of Excellence for Suicide Prevention. Joint Department of Veterans Affairs (VA) and Department of Defense (DoD) Suicide Data Repository: National Death Index (NDI). http:\/\/vaww.virec.research.va.gov\/Mortality\/Overview.htm. Accessed December 2018."},{"key":"joi190099r34","unstructured":"Food and Drug Administration. FDA drug safety communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. https:\/\/www.fda.gov\/Drugs\/ood DrugSafety\/ucm493244.htm. Published 2016. Accessed April 8, 2016."},{"key":"joi190099r35","unstructured":"European Medications Agency. Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/metformin-metformin-containing-medicines. Accessed June 13, 2019."},{"key":"joi190099r36","unstructured":"Diabetes Canada. Canadian Journal of Diabetes. https:\/\/guidelines.diabetes.ca\/docs\/CPG-2018-full-EN.pdf. Published April 2018. Accessed June 13, 2019."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2751397\/jama_roumie_2019_oi_190099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T15:00:53Z","timestamp":1569337253000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2751397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,9,24]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.13206","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,24]]}}}